This inventor holds 2 USPTO granted patents. Top assignees: Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd, Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Feina Tu: Innovator in Breast Cancer Treatment
Introduction
Feina Tu is a prominent inventor based in Shenzhen, China. She has made significant contributions to the field of medical science, particularly in the diagnosis and treatment of breast cancer. Her innovative approach has the potential to change the landscape of cancer treatment.
Latest Patents
Feina Tu holds a patent for the use of mitoxantrone preparation in the preparation of a drug for diagnosing and treating breast cancer. This patent outlines the use of mitoxantrone and/or a pharmaceutically acceptable salt in the preparation of a lymphatic tracer for diseases associated with breast resection. The preparation has shown no local or systemic toxic and side effects after local injection, indicating good tolerance, effectiveness, and safety. This innovation provides a new treatment idea for thoroughly curing breast cancer in patients.
Career Highlights
Throughout her career, Feina Tu has worked with notable companies such as Shenzhen China Resources Jiuchuang Medical and Pharmaceutical Co., Ltd and Shenzhen China Resources Gosun Pharmaceuticals Co., Ltd. Her work in these organizations has allowed her to develop and refine her innovative ideas in the medical field.
Collaborations
Feina Tu has collaborated with esteemed colleagues, including Jun Liu and Xun Li. These partnerships have contributed to her success and the advancement of her research.
Conclusion
Feina Tu is a trailblazer in the field of breast cancer treatment, with her innovative patent offering new hope for patients. Her contributions to medical science are invaluable, and her work continues to inspire future innovations in cancer therapy.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile